KRAS wild-type cancers had lower GALNT6 mRNA expression levels than KRAS mutated cancers, whereas BRAF mutated tumors had lower GALNT6 mRNA expression levels than BRAF wild-type tumors. The gene discussed is BRAF; the disease is cancer.